IONIS PHARMACEUT reported $2.36M in Interest Expense on Debt for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Interest Expense On Debt Change
Alnylam Pharmaceuticals ALNY:US $ 33.42M 901K
Arena Pharmaceuticals ARNA:US $ 1.05M 0.02M
Biocryst Pharmaceuticals BCRX:US $ 13.5M 0.59M
Biomarin Pharmaceutical BMRN:US $ 3.82M 0.01M
Dicerna Pharmaceuticals DRNA:US $ 0M 0M
Esperion Therapeutics ESPR:US $ 11.14M 3.02M
Gw Pharmaceuticals GWPH:US $ 0.29M 0.02M
Halozyme Therapeutics HALO:US $ 1.75M 0.21M
Intercept Pharmaceuticals ICPT:US $ 12.59M 0.17M
Moderna Inc MRNA:US 5M 2M
Nektar Therapeutics NKTR:US $ 13.09M 0.21M
Neurocrine Biosciences NBIX:US $ 6.2M 0.2M
Novartis NOVN:VX 201M 1000K
Omeros OMER:US $ 4.91M 13K
Pfizer PFE:US $ 316M 20M
Ptc Therapeutics PTCT:US $ 22.56M 2.7M
Regeneron Pharmaceuticals REGN:US $ 14.4M 0.2M
Sarepta Therapeutics SRPT:US $ 15.83M 0.18M
Vertex Pharmaceuticals VRTX:US $ 15.48M 0.2M